CytoImmune Therapeutics vs Hercules Pharmaceuticals

CytoImmune Therapeutics logo

CytoImmune Therapeutics

CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients

31 employees · est. 2019 · Monrovia, United States

VS
Hercules Pharmaceuticals logo

Hercules Pharmaceuticals

Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid Tumors

est. 2013

Hercules Pharmaceuticals is the older company (2019 vs 2013).

Side-by-Side Comparison

CytoImmune Therapeutics Hercules Pharmaceuticals
Founded
2019 2013 older
Headquarters
Monrovia, United States Not tracked yet
Employees
31 Not tracked yet
Industry
Biotechnology, Health and Wellness Biopharma, Biotechnology
Funding Stage
Not tracked yet Seed
Total Funding
Not tracked yet $300.00K
Funding Rounds
Not tracked yet 1
Taxonomy
ImmunotherapyBi-specific AntibodyCAR TechnologyNK Cell TherapyT-cell TherapyCoordinated Immunotherapy +8 BiopharmaceuticalOral TherapyNon-toxicTriple Negative Breast CancerSolid TumorsAryl Hydrocarbon Receptor +9
Website
cytoimmune.com hercules-pharma.nl
CytoImmune Therapeutics logo

About CytoImmune Therapeutics

CytoImmune Therapeutics is a biotechnology startup with a vision to develop novel, coordinated immunotherapy solutions for patients. The company's CoalesceNT™ platform integrates bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to orchestrate an immune response with natural...

Hercules Pharmaceuticals logo

About Hercules Pharmaceuticals

Hercules Pharmaceuticals is a biopharmaceutical company founded in 2013 with a mission to develop innovative, oral, non-toxic drug therapies for patients with Triple Negative Breast Cancer and other solid tumors. The company's focus on inhibiting the Aryl hydrocarbon Receptor in solid tumors has sho...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches CytoImmune Therapeutics and Hercules Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when CytoImmune Therapeutics or Hercules Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

CytoImmune Therapeutics was founded in 2019, based in Monrovia, United States, with 31 employees. CytoImmune Therapeutics is a biotechnology startup with a vision to develop novel, coordinated immunotherapy solutions for patients. The company's CoalesceNT™ platform integrates bispecific antibody (. Hercules Pharmaceuticals was founded in 2013. Hercules Pharmaceuticals is a biopharmaceutical company founded in 2013 with a mission to develop innovative, oral, non-toxic drug therapies for patients with Triple Negative Breast Cancer and other s.
CytoImmune Therapeutics has raised no disclosed funding and Hercules Pharmaceuticals $300.00K. Latest stage: Hercules Pharmaceuticals Seed.
Both work in Biotechnology and list immunotherapy, cancer treatment and oncology among their focus areas.

Compare CytoImmune Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at CytoImmune Therapeutics on 18 Nov 2024, and Hercules Pharmaceuticals on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes